SCHEMBL4985140

SCHEMBL4985140

NC(=O)c1n[c]c2c(n1)CN(S(=O)(=O)c1cccc(Oc3ccc(Cl)c(Cl)c3)c1)CC2

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.41
AKR1C3 P42330 7/20 0.39
AKR1C2 P52895 2/20 0.36
AKR1C1 Q04828 2/20 0.36
CHEK2 O96017 1/20 0.36
GAA P10253 2/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
KMO O15229 1/20 0.35
LGALS8 O00214 1/20 0.35
LGALS3 P17931 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
SCN9A Q15858 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4988175 0.86 AKR1C3 (0.47) AKR1C3GAAALDH1A1LMNAKMT2A
SCHEMBL4980960 0.84 SMN1; SMN2 (0.46) FAAHAKR1C3ALDH1A1LMNAMAPT
SCHEMBL4989343 0.83 AKR1C3 (0.44) AKR1C3AKR1C1GAAALDH1A1LMNA
SCHEMBL4988642 0.81 MAPT (0.43) AKR1C3AKR1C2AKR1C1ALDH1A1LMNA
SCHEMBL5145783 0.80 FAAH (0.40) FAAHAKR1C3AKR1C2AKR1C1ALDH1A1
SCHEMBL4992564 0.80 MEN1 (0.47) AKR1C3AKR1C1GAALMNAMEN1
SCHEMBL4985245 0.80 LMNA (0.38) FAAHAKR1C3ALDH1A1LMNAHTT
SCHEMBL4983067 0.80 PKM (0.43) GAAALDH1A1LMNAMEN1MAPT
SCHEMBL4988448 0.80 MEN1 (0.45) AKR1C3AKR1C1GAAALDH1A1MEN1
SCHEMBL4986174 0.80 PKM (0.46) AKR1C3AKR1C1GAALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 FAAH 494/4885AKR1C3 1419/4885AKR1C2 2324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.